Solve M.E. Spearheads Formation of Long COVID Alliance to Accelerate Post-Infectious Research


Today, Solve M.E. warmly welcomes 50 new partners in the fight to return millions of Americans to health. The Long COVID Alliance, launched by Solve M.E., is a network of patient-advocates, scientists, disease and public health experts, and drug developers, who have joined together to leverage our collective knowledge and resources to educate policy makers and accelerate research to transform our understanding of post-infectious illness.

In 2020, Solve M.E. organized 20 organizations who came together to call for urgent government investments for Long COVID research. This successful advocacy effort helped secure $1.15 billion for National Institutes of Health (NIH) research and laid the foundations of the Long COVID Alliance.

Read more about the launch of the Long COVID Alliance here.

To accompany the Long COVID Alliance’s launch, the initial partners from 2020 have drafted key recommendations and guidance for the NIH. We also included a list of scientific initiatives from the ME/CFS research community to highlight their importance and priority for NIH decision makers. You can view the complete letter here.

To learn more about the Long COVID Alliance, please visit